Featured in Ebola
Regardless of COVID-19’s origins, experts say it’s time to tighten up biosecurity lab protocols
BSL-4 labs are somewhat risky, and they're not very well managed.
Remdesivir is the first FDA-approved COVID-19 treatment. Here’s what to know about it.
A new wave of studies convinced the US government to make the drug an option for non-pediatric hospitalized patients.
Tracking down ‘patient zero’ is a crucial piece of the pandemic puzzle
Epidemiologists pair gumshoe detective skills with fancy lab equipment to work backwards and stave off viral spread.
Ebola hasn’t been cured yet, but two experimental drugs are showing significant progress
“It’s premature to say that this is a curative treatment. We should be optimistic, but not overstate.”
We’re in the middle of the second-deadliest Ebola outbreak ever
The hemorrhagic fever has infected more than 1,000 in the Democratic Republic of Congo.
A female Ebola survivor infected her family more than a year after she had the illness
A case study in how viruses are sneakier than we sometimes think.
Can this flu drug really stop Ebola in its tracks?
The unusual uses of off-label drugs.
Vaccines of the future could be as contagious as viruses
It’s time to go viral.
This vaccine just might stop Ebola from annihilating the great apes
It worked in the lab—but will it work in the jungle?
Ebola may be better at hiding than we thought
One study found a disturbing number of undetected carriers